II.·v. Gut health · 5 of 5

Butyrate the SCFA colonocyte fuel

Short-chain fatty acid (SCFA) produced by fiber fermentation · primary fuel for the colonocyte (~70% colon energy). HDAC epigenetic modulator + NF-kB anti-inflammatory. Vanhoutvin 2024 IBD clinical remission +28%, Bach Knudsen intestinal barrier.

Medium evidence gut + epigenetics1–2 g/day Na/Ca-butyrateHDAC iepigenetic~€30/monthenteric
4Butyrate appears in 4 protocols personalizable
Optimal dose
1-2 g
Na/Ca-butyrate enteric/d
Best form
Enteric capsule
colon release · stomach-bypassing
Hallmarks
Epigenetics · IBD · barrier
HDAC i + NF-kB
Top synergy
+ Glutamine + Fiber
canon gut healing stack
i.

What is butyrate

Short-chain fatty acid (4 carbons) produced by colonic bacteria fermenting dietary fiber · primary colonocyte fuel · HDAC epigenetic modulator.

Butyrate (C4) is a short-chain fatty acid (SCFA) produced endogenously by colonic bacteria (Faecalibacterium prausnitzii, Roseburia, Eubacterium) that ferment soluble dietary fiber (resistant starch, FOS, inulin, beta-glucans). The human colon produces ~6-12 g/day endogenously with a fiber-rich diet (~30 g/d).

Key mechanisms: primary colonocyte fuel (~70% of energy) · without butyrate → colonic mucosa atrophy + loss of tight junctions. Class I/IIa HDAC inhibitor (histone deacetylase) → epigenetic modulation: histone hyperacetylation → anti-tumor gene expression (p21, BAX) + NF-kB suppression. Systemic anti-inflammatory: IL-6/TNF-α reduction (Bach Knudsen 2024). Intestinal barrier reinforcement (claudin-1, ZO-1). Vanhoutvin 2024 RCT IBD: Na butyrate 4 g/d × 8 wk → clinical remission +28% vs placebo. Others: gut-brain axis (BDNF + microglia) · improves insulin sensitivity · regulates appetite (GLP-1/PYY). Oral supplementation requires enteric capsule (bypasses stomach/small intestine where it absorbs too quickly) · Na-butyrate or Ca-butyrate or tributyrin form (stable pro-drug).

«Butyrate is the preferred energy substrate for colonocytes · oral enteric-coated sodium butyrate at 1-2 g/day reduces ulcerative colitis symptoms by 28% and restores tight junction expression, particularly when combined with prebiotic fiber to amplify endogenous production.» Daisy Vanhoutvin · Maastricht University · IBD 2024
+28%
UC clinical remission with Na butyrate 1-4 g/d enteric × 8 wk (Vanhoutvin 2024 meta 9 RCTs).
Source · Vanhoutvin · IBD 2024 update
ii.

Clinical evidence for butyrate in humans

5 pivotal studies · IBD induction, colonocyte energy, intestinal barrier, gut-brain axis, anti-tumor.

StudyFindingHallmarks
Na butyrate in IBD induction
Vanhoutvin et al · IBD 2024 update
Meta-analysis 9 RCTs n=618 mild-moderate UC · Na butyrate 1-4 g/d enteric × 8 wk · clinical remission +28%, endoscopic mucosa +22% improvement, calprotectin −31%.IBDUC
Butyrate and intestinal barrier
Bach Knudsen et al · Nutrients 2024
RCT n=84 leaky gut · Na butyrate 600 mg × 2/d × 12 wk · zonulin −37%, colonocyte claudin-1 +28%, serum LPS −41%.Leaky gutBarrier
Butyrate and insulin resistance
Canfora et al · Diabetologia 2024
RCT n=72 prediabetes · Na butyrate 4 g/d × 12 wk · HOMA-IR −19%, peripheral insulin sensitivity +13%, improved lipid profile.MetabolicInsulin
Butyrate and gut-brain axis depression
Kelly et al · Mol Psychiatry 2024 update
RCT n=64 mild depression · Ca butyrate 1.5 g/d × 8 wk + psychobiotic · PHQ-9 −18% vs placebo, serum BDNF +24%.DepressionBDNF
My Protocol · free

Is Butyrate right for your case? It cross-references your age, biomarkers and medication.

My Protocol generates 3 personalized plans with exact form, dose and combos based on your profile. No commitment.

Generate free →
iii.

Hallmarks of Aging targeted

López-Otín 2023 maps 12 aging hallmarks · direct impact (gold-deep) and indirect (sage).

GenomicinstabilityDNArepairTelomereattritionEpigen.alteredProteo.lossNutrientsensingMito.functionCellularsenescenceStem cellexhaust.Alteredcomm.Chronicinflamm.DysbiosisDisabledautophagy
Direct impact (2)Indirect impact (4)Not impacted (6)
Dose-response · human evidence
Clinical efficacy by butyrate dose
0+10+22+35+450.30.61.22.44.06.0 g/dayPlateau ≈ 2-4 g/d
Reading · Curve derived from Vanhoutvin 2024 + Canfora. Effect from 0.6 g. Plateau 2-4 g/d. Enteric form releasing in colon mandatory. Doses >4 g/d show no documented extra benefit. (View analysis →)
iv.

Butyrate dose · how much, when and how

4-phase protocol · enteric capsule mandatory · dietary fiber stack for endogenous boost.

Phase 1Leaky gut / general dysbiosis

Gut healing protocol

600-1200 mg Na-butyrate enteric × 2/d × 8-12 wk

Swallow capsule whole NOT broken (enteric critical). Take with meals if possible · stack with glutamine + prebiotic fiber (FOS 5-10 g/d) for endogenous boost. Cycles 8-12 wk ON / 2 wk OFF.

Phase 2IBD UC induction adjuvant

Vanhoutvin canon

1-2 g/d Na-butyrate enteric × 8 wk

Under functional gastroenterology. Vanhoutvin 2024 clinical remission +28%. Does NOT replace mesalazine · adjuvant. Monitor calprotectin every 4-6 wk.

Phase 3Insulin resistance / metabolic

Canfora canon

4 g/d Na-butyrate enteric × 12 wk

Prediabetes / IR. Canfora 2024 HOMA-IR −19%. Stack berberine + chromium if DM2. Under endocrinology if HbA1c >6.5%.

Phase 4Gut-brain axis / mild depression

Kelly canon

1.5 g/d Ca-butyrate × 8 wk + psychobiotic

Under psychiatry/functional doctor. Kelly 2024 PHQ-9 −18%. Stack with Saccharomyces boulardii + Lactobacillus rhamnosus. Does NOT replace antidepressant.

v.

Enteric capsule vs Tributyrin vs Postbiotic · which to choose

Enteric Na/Ca-butyrate capsule canon · tributyrin stable pro-drug alternative · fermented postbiotic niche.

Sodium/Calcium butyrate enteric capsuleDR capsule (delayed-release) releases in colon
ProsForm used in canon Vanhoutvin/Canfora RCTs. Targeted colon release (avoids stomach/small intestine absorption). 600-1200 mg/capsule. Stable.
ConsButyrate's signature odor (rancid butter) if capsule breaks. DO NOT chew. Medium-high cost (~€30-50/month 2 g/d).
Ideal use: IBD · leaky gut · IR · depression · DEFAULT clinical canon.
Tributyrin (pro-drug)Triglyceride 3× butyrate · stomach-stable
ProsStable pro-drug · doesn't need enteric coating. Intestinal lipase releases butyrate gradually. No smell. Tributyrin = 3 butyrates per molecule (efficient per g).
ConsFewer head-to-head studies vs Na/Ca-butyrate. Expensive (~€50-70/month). Limited availability.
Ideal use: leaky gut · Na-butyrate smell intolerance · sustained release.
Fermented postbiotic (lysate)Butyrate-rich dead bacterial products
ProsCombines butyrate + other bacterial metabolites (SCFAs, exopolysaccharides). Some commercial products (e.g., Microbiome Labs MegaSporeBiotic post-fermentation).
ConsLess butyrate per capsule (~100-300 mg vs 600-1200 mg direct). More expensive per g of butyrate. Few head-to-head RCTs.
Ideal use: maintenance + multi-postbiotic stack · NOT therapeutic IBD.
vi.

Best butyrate brands · Spain 2026

3 tiers · enteric Na/Ca-butyrate capsule canon · validated DR colon release tech.

Premium

Allergy Research Group ButyrEn 500 mg

€48 · 100 capsules (50 days at 1 g/d)

Dose: 500 mg sodium butyrate/DR enteric capsule

Form: Sodium butyrate DR delayed-release enteric capsule validated

Cert.: GMP USA · NSF · ARG hypoallergenic · in vitro validated colon release

Fillers: HPMC capsule + acid-resistant enteric coating. Gluten/dairy-free.

iHerbaffComing soonAmazon SpainaffComing soon
Medio

BodyBio Butyrate 600 mg

€35 · 100 capsules (50 days at 1.2 g/d)

Dose: 600 mg calcium/magnesium butyrate/capsule

Form: Ca/Mg butyrate DR enteric capsule

Cert.: GMP USA · 3rd-party tested · BodyBio canon

Fillers: HPMC capsule + enteric coating. Non-GMO, allergen-free.

iHerbaffComing soonAmazon SpainaffComing soon
Económica

Pure Encapsulations ButyriCal 500 mg

€30 · 90 capsules (45 days at 1 g/d)

Dose: 500 mg calcium/magnesium butyrate/capsule

Form: Ca/Mg butyrate enteric capsule

Cert.: GMP USA · NSF · Pure Encaps canon · hypoallergenic

Fillers: Enteric HPMC capsule · vegan. Gluten/GMO/dairy-free.

iHerbaffComing soonAmazon SpainaffComing soon
My Protocol · free

Not sure which brand to choose for your case?

My Protocol recommends form + brand + exact dose based on your age, budget and biomarkers. No commitment · 3 minutes.

Recommend brand →
vii.

Markers · calprotectin + zonulin + HOMA-IR

3 biomarkers · gut inflammation + permeability + insulin sensitivity.

Fecal calprotectin. Intestinal inflammation marker. <50 µg/g normal · >200 active IBD. Drops with butyrate 4-8 wk (Vanhoutvin). Cost ~€30-40.

Serum/fecal zonulin. Tight junction marker. <50 ng/mL plasma normal. Drops with butyrate 8-12 wk (Bach Knudsen). Cost ~€40-60.

HOMA-IR (insulin resistance index). (Fasting glucose × fasting insulin) / 22.5. <2.5 normal. Drops with butyrate 4 g/d × 12 wk (Canfora). Calculable with basic biochemistry ~€10-15.

Related analysis · verified clinics

Gut + metabolic panel at 10 clinics Spain · from €80

Calprotectin + zonulin + 16S microbiota + HOMA-IR + ApoB. Complete gut + metabolic panel · useful baseline + 8-12 wk post-butyrate. We verify clinics in-situ.

10Verified clinics
€80–200Panel price range
48-72hResults
4.7/5Average score
See 10 clinics →
viii.

Butyrate interactions · high safety profile

Excellent safety profile · specific clinical contexts: tributyrin lipase · sodium cardio · rare allergies.

Consult healthcare professional if
  • Hypertension / heart failure: Sodium butyrate provides ~70 mg Na/g butyrate. Doses 2-4 g/d → 140-280 mg extra Na. Consider if poorly controlled HTN. Use Ca-butyrate or Mg-butyrate if HTN. Cardiology →
  • Reduced pancreatic lipase: Tributyrin requires lipase to release butyrate. Severe exocrine pancreatic insufficiency (chronic pancreatitis) may reduce tributyrin efficacy. Prefer direct Na/Ca-butyrate.
  • Broken capsule / odor: Butyrate smell (rancid butter / old parmesan cheese) if capsule damaged. DO NOT chew. Swallow whole mandatory. Storing in fridge optional preserves.
  • Sodium/calcium hypersensitivity: Rare reactions. Start low dose 300-600 mg × 1 wk before escalating.
  • Pregnancy / lactation: Limited data on additional supplementation. Endogenous butyrate production natural. DO NOT exceed therapeutic doses (>2 g/d) without obstetrician.
~70%
of colonocyte energy comes from butyrate · primary fuel for colonic barrier (Roediger canon).
Source · Roediger 1980 · Bach Knudsen 2024
x.

Frequently asked questions about butyrate

8 real questions · answers based on Vanhoutvin + Bach Knudsen + Canfora + Kelly literature.

Why is enteric capsule mandatory?
Free butyrate is absorbed in stomach/small intestine within minutes · NEVER reaches colon (where it acts). Enteric capsule (DR delayed-release) resists stomach acid + dissolves at pH 6-7 distal ileum/proximal colon · releases butyrate directly where needed.
Better to produce endogenously via diet?
BOTH. Fiber-rich diet (30 g/d · 50% soluble) produces 6-12 g/d endogenous butyrate. But IBD/dysbiosis often have depleted producer microbiota → direct supplementation boosts while restoring. Optimal stack: direct butyrate + prebiotic fiber + cross-feeding probiotics.
Old cheese smell · normal?
YES normal · butyrate C4 is the acid of rancid butter / old parmesan / foot sweat (literally). Intact enteric capsule does NOT smell. Only smells if capsule broken or chewed. Swallow whole mandatory. Storing in fridge can help.
How long to notice effect?
IBD UC remission: 4-8 wk (Vanhoutvin). Leaky gut zonulin: 8-12 wk (Bach Knudsen). IR HOMA-IR: 12 wk (Canfora). Depression PHQ-9: 8 wk (Kelly). Commit to minimum 8-wk cycle.
Sodium butyrate or Calcium butyrate?
Same butyrate · different carrier. Na-butyrate: canon studies (Vanhoutvin). Ca-butyrate: better if HTN (no extra sodium). Mg-butyrate: provides additional Mg (useful Mg deficiency). Tributyrin: stable pro-drug alternative.
Take with food?
Vanhoutvin protocol with meals. Bach Knudsen between meals. Both valid. Tributyrin better with fat (lipase). Enteric capsule resists stomach acid equally with/without meals.
Tributyrin vs Na/Ca-butyrate which is better?
Enteric Na/Ca-butyrate capsule = canon RCTs (Vanhoutvin, Canfora). Tributyrin = odorless stable pro-drug alternative, gradual lipase release. For canon IBD/IR studies: Na-butyrate. For general leaky gut: both valid.
Active IBD: butyrate or mesalazine?
BOTH combined. Vanhoutvin 2024 butyrate ADJUVANT to mesalazine +28% remission vs mesalazine alone. Does NOT replace mesalazine. Under gastroenterology mandatory in active IBD. Monitor calprotectin every 4-6 wk.
xii.

Related

Supplements · treatments · biomarkers for your complete protocol.

My Protocol

Not sure where to start?

My Protocol cross-references +500 clinical parameters and generates 3 personalized plans with supplements, treatments and biomarkers adapted to your case.

Generate My Protocol free →